Diabetes — all decisions

The Board remands the claims for service connection for colon cancer, hypertension, diabetes mellitus, vision condition (secondary to diabetes mellitus), erectile dysfunction, headaches, and peripheral neuropathy of the left foot/heel due to a need for additional development, including VA examinations.

The Board granted service connection for allergic rhinitis and remanded the other claims for further development.

The Board granted service connection for diabetes mellitus Type II, hypertension, bilateral femoral stents for peripheral vascular disease (PVD), and heart disability, but denied service connection for Parkinson's disease.

The Board denied service connection for all the claimed conditions as there was no evidence of a current disability or that any of the disabilities were related to active duty.

The Board granted a 30 percent rating for pancreatic exocrine insufficiency and denied an earlier effective date and a higher rating for diabetes mellitus type II.

The Board denied service connection for deep vein thrombosis, hyperlipidemia, vitamin D deficiency, pre-diabetes, and obstructive sleep apnea. The Veteran's hypertension was not found to be compensable, and the ratings for his depressive disorder and tinnitus were also denied.

The Board granted service connection for diabetes mellitus type 2 and remanded the claims for a back condition, peripheral artery disease, pes planus, and right foot or toe condition.

The Board granted service connection for depressive disorder with anxiety disorder and bilateral lower extremity diabetic neuropathy, atherosclerotic cardiovascular disease, and chronic kidney disease, all secondary to diabetes mellitus. A 30 percent initial rating was granted for stasis dermatitis.

The Board denied the Veteran's claim for special monthly compensation (SMC) based on aid and attendance, as her need for assistance is not solely due to service-connected disabilities.

The Veteran was granted a 10 percent rating for his right eye disability effective February 22, 2022.

The Board remands the claims for service connection for an endocrine disorder, to include diabetes, and obstructive sleep apnea (OSA) due to a need for additional evidence regarding potential exposures during service.

The Board granted service connection for right ear hearing loss, tinnitus, diabetes mellitus type II, and Parkinson's disease.

The Board denied the Veteran's claim for an initial compensable disability rating for diabetic retinopathy as there were no incapacitating episodes or visual impairment.

The Board granted service connection for diabetes mellitus type II, hypertension, hypothyroidism, prostate cancer, sleep apnea secondary to service-connected diabetes mellitus, tinea pedis, and lumbar spondylosis.

The Board denied service connection for diabetes mellitus, valvular heart disease (chest pain and cardiac valve stenosis), aortic aneurysm, and hypertension as these conditions were not found to be etiologically related to the Veteran's active duty service.

The Veteran was granted special monthly compensation (SMC) based on the need for aid and attendance from July 28, 2023, through September 21, 2024.

The Board remands the claims for service connection for diabetes mellitus, hypertension, adenocarcinoma of the prostate, and erectile dysfunction due to inadequate toxic exposure risk activities (TERA) memoranda and a need for additional medical opinions.

The Board denied the veteran's claims for an earlier effective date for his diabetes mellitus, a higher rating for PTSD with alcohol use disorder, and a total disability rating due to service-connected disabilities.

The Board granted service connection for diabetes mellitus but denied it for bilateral hearing loss.

The Board denied service connection for multiple conditions, including fatigue, bilateral eye disability, hypertension, diabetes mellitus, GERD, penile condition, left foot disability, and others. Some claims were remanded for further development.